1-171319894-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002022.3(FMO4):āc.69T>Gā(p.Asp23Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002022.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMO4 | NM_002022.3 | c.69T>G | p.Asp23Glu | missense_variant | 3/10 | ENST00000367749.4 | NP_002013.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FMO4 | ENST00000367749.4 | c.69T>G | p.Asp23Glu | missense_variant | 3/10 | 1 | NM_002022.3 | ENSP00000356723.3 | ||
FMO4 | ENST00000475780.5 | n.399T>G | non_coding_transcript_exon_variant | 3/5 | 2 | |||||
FMO4 | ENST00000497228.5 | n.349-3110T>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251234Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135766
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461590Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 727100
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.69T>G (p.D23E) alteration is located in exon 3 (coding exon 1) of the FMO4 gene. This alteration results from a T to G substitution at nucleotide position 69, causing the aspartic acid (D) at amino acid position 23 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at